โ† All deals

Vesalius Longevity Labs Inc.

PharmaceuticalsLongevityPeptidesPharmaceuticals
๐Ÿ“ Vancouver, Canadaโ€ข Founded 2024
StreetZero Signal 65
Be the first to signal interest

About Vesalius Longevity Labs Inc.

Vesalius Longevity Labs Inc. is a longevity science and regenerative health platform focused on peptides, biologics, preventative healthcare and performance optimization. It operates a prescriber-led, quality-first model that connects licensed healthcare providers with peptide therapeutics globally through a scalable B2Doctor distribution network across North America, Europe, UAE, Asia Pacific, and Latin America. The company is on a path to become the first publicly traded company dedicated exclusively to longevity science and peptides.

LATEST FUNDINGPrivate Placement
$6.5M
Announced 2026-11-18
TOTAL RAISED$6.5M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Vesalius Longevity Labs Inc..

Free plan includes 3 full deal profiles every month.

Investors

Key highlights

  • Raised US$6.5 million in strategic financing led by investor group organized by Harvey Spevak.
  • Partnership announced with Wisp to launch women-centric peptide therapy offerings.
  • Operates global distribution network for licensed healthcare providers across multiple continents.
  • Aims to be the first publicly traded company focused exclusively on peptides and longevity science.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account